Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Twist Bioscience Corporation

Twist Bioscience Corporation (TWST) Stock Overview

Explore Twist Bioscience Corporation’s financial performance, market position, analyst ratings, and future outlook.

TWST●NASDAQ
HealthcareBiotechnology
$134.75
$7.53(5.92%)
U.S. Market opens in NaNh NaNm

Twist Bioscience Corporation (TWST)

Meyka AI Score

Z

Key Financials

Market Cap8.4B
P/E Ratio-57.80
EPS (TTM)$-2.22
ROE-0.30%
Fundamental Analysis

AI Price Forecasts

1 Month$129.16
3 Months$135.30
1 Year Target$52.30

TWST Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Twist Bioscience Corporation (NASDAQ: TWST) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Twist Bioscience Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TWST on the NASDAQ shows an RSI of 56.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $52.30 for the NASDAQ listing.

Key metrics behind Twist Bioscience Corporation's NASDAQ-traded stock include a P/E ratio of -57.80 and a market capitalization of 8.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TWST on the NASDAQ.

Price Performance (NASDAQ: TWST)

1-Day Change
5.92%
5-Day Change
6.51%
1-Month Change
13.65%
3-Month Change
76.91%
6-Month Change
211.34%
Year-to-Date (YTD) Change
324.81%
1-Year Change
423.91%
3-Year Change
512.78%
5-Year Change
18.12%
All-Time (Max) Change
862.50%

Contact Information

https://www.twistbioscience.com
800 719 0671
681 Gateway Boulevard, South San Francisco, CA, 94080

Company Facts

9,790 Employees
IPO DateOct 31, 2018
CountryUS
Actively Trading

Frequently Asked Questions